Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Fibroadenoma Companies

ID: MRFR/Pharma/2680-CR
208 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Fibroadenoma companies focus on providing medical solutions for individuals with fibroadenomas, non-cancerous breast tumors commonly found in young women. These companies contribute to breast health by offering diagnostic tools, imaging technologies, and treatment options, including surgical interventions, for managing fibroadenomas.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Fibroadenoma Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.36%
2024 Market Size$ 0.77 Billion
2025 Market Size$ 0.82 Billion
2035 Market Size$ 1.52 Billion
Key Players
GE Healthcare
Siemens Healthineers
Philips Healthcare
Hologic
Canon Medical Systems
Fujifilm Holdings Corporation
Opportunities
  • Rising Incidence of Fibroadenoma Cases
  • Growing Investment in Breast Health Research
  • Increased Focus on Women's Health Initiatives

Top Industry Leaders in the Fibroadenoma Market

Fibroadenoma companies
 

Latest Fibroadenoma Companies Updates:

Jan 2024

Siemens Healthineers Launched their new ACUSON S2000 ultrasound system with enhanced image resolution and AI-powered tools for accurate fibroadenoma diagnosis.Collaborated with research institutions to develop novel ultrasound biomarkers for differentiating fibroadenomas from other breast lesions.

GE Healthcare Introduced their LOGIQ E10 ultrasound system featuring advanced needle guidance capabilities for improving FNA biopsy accuracy and patient comfort.Focused on developing artificial intelligence and deep learning algorithms for automated fibroadenoma detection and classification on ultrasound images.

Illumina Developed a next-generation genetic testing panel for breast cancer risk assessment, including analysis of genes associated with fibroadenoma development.Partnered with biobanks and research groups to investigate the genetic basis of fibroadenomas and their potential link to breast cancer risk.

EchoNous Introduced their AI-powered breast ultrasound analysis software offering automated detection and characterization of fibroadenomas, potentially reducing unnecessary biopsies.Collaborated with healthcare providers to implement their software and improve diagnostic workflow efficiency in fibroadenoma cases.

American College of Radiology Updated their breast imaging guidelines emphasizing the importance of ultrasound for diagnosing fibroadenomas and reducing unnecessary surgical procedures.Launched educational initiatives for healthcare professionals and patients to raise awareness about fibroadenomas and appropriate management strategies.

List of Fibroadenoma Key companies in the market

  • IceCure Medical, Inc.
  • Alpinion Medical Systems Co., Ltd.
  • SonaCare Medical, LLC.
  • Insightec
  • Torrent Pharmaceuticals Ltd
  • Taj Pharmaceuticals Ltd.
  • Novartis Pharmaceuticals Limited
  • Torrent Pharmaceuticals Limited